Medicine
Moxifloxacin 5 mg/mL ophthalmic solution
Moxifloxacin 5 mg/mL ophthalmic solution is a generic prescription medicine for ophthalmic use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 2°C to 25°C (36°F to 77°F).
Key facts
- Active ingredient (INN)
- Moxifloxacin
- Brand
- Sold under the generic name
- Strength
- 5 mg/mL
- Dosage form
- Ophthalmic solution
- Route
- Ophthalmic
- Packs
- 3 mL, 1 bottle
- Manufacturers
- LupinIndiaAsclemedUpsher-Smith Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 2°C to 25°C (36°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01MA14 Moxifloxacin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 February 2020
- Identifiers
- RxCUI 403818DailyMed set ID 5a5d72e2-aa39-4ead-af72-d3cabe72a5b7, d66f080b-da56-4473-8785-920d9700f72d, 8f92f110-32d6-4d0c-a415-7a9a4cafb9b8NDC 0832-1410, 68180-421, 76420-331Application ANDA212616, ANDA204079
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 mL in 1 bottle | 68180-421-01 | LupinIndia | 13 February 2020 |
| 1 bottle, plastic in 1 carton / 3 mL in 1 bottle, plastic | 0832-1410-03 | Upsher-Smith Laboratories | 10 February 2021 |
| 1 bottle, plastic in 1 carton / 3 mL in 1 bottle, plastic | 76420-331-03 | Asclemed | 19 April 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 December 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Moxifloxacin
Clinical summary
Moxifloxacin is a fluoroquinolone antibacterial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. It is available as eye drops, tablets and injection for ophthalmic, oral and intravenous use. MedsAcross supplies Moxifloxacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MoxifloxacinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VIGAMOX prescribing information (Harrow Eye) · U.S. National Library of Medicine, DailyMed
Need Moxifloxacin 5 mg/mL ophthalmic solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.